281 related articles for article (PubMed ID: 29973089)
1. Biomedical applications of prokaryotic carbonic anhydrases.
Supuran CT; Capasso C
Expert Opin Ther Pat; 2018 Oct; 28(10):745-754. PubMed ID: 29973089
[TBL] [Abstract][Full Text] [Related]
2. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):325-32. PubMed ID: 24766661
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
Capasso C; Supuran CT
Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
[TBL] [Abstract][Full Text] [Related]
4. Biomedical applications of prokaryotic carbonic anhydrases: an update.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2024 May; 34(5):351-363. PubMed ID: 38840307
[TBL] [Abstract][Full Text] [Related]
5. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
Capasso C; Supuran CT
Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
[TBL] [Abstract][Full Text] [Related]
6. Recombinant thermoactive phosphoenolpyruvate carboxylase (PEPC) from Thermosynechococcus elongatus and its coupling with mesophilic/thermophilic bacterial carbonic anhydrases (CAs) for the conversion of CO2 to oxaloacetate.
Del Prete S; De Luca V; Capasso C; Supuran CT; Carginale V
Bioorg Med Chem; 2016 Jan; 24(2):220-5. PubMed ID: 26712095
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2024 Jun; 34(6):465-474. PubMed ID: 38506448
[TBL] [Abstract][Full Text] [Related]
8. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
Aggarwal M; McKenna R
Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
[TBL] [Abstract][Full Text] [Related]
9. New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences.
Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1254-60. PubMed ID: 27353388
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.
Supuran CT; Capasso C
Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966
[TBL] [Abstract][Full Text] [Related]
11. A failed tentative to design a super carbonic anhydrase having the biochemical properties of the most thermostable CA (SspCA) and the fastest (SazCA) enzymes.
De Luca V; Del Prete S; Carginale V; Vullo D; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):989-94. PubMed ID: 25683084
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrases--an overview.
Supuran CT
Curr Pharm Des; 2008; 14(7):603-14. PubMed ID: 18336305
[TBL] [Abstract][Full Text] [Related]
13. Thermostable Carbonic Anhydrases in Biotechnological Applications.
Di Fiore A; Alterio V; Monti SM; De Simone G; D'Ambrosio K
Int J Mol Sci; 2015 Jul; 16(7):15456-80. PubMed ID: 26184158
[TBL] [Abstract][Full Text] [Related]
14. Catalytic mechanism of α-class carbonic anhydrases: CO2 hydration and proton transfer.
Boone CD; Pinard M; McKenna R; Silverman D
Subcell Biochem; 2014; 75():31-52. PubMed ID: 24146373
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
Del Prete S; Vullo D; De Luca V; Carginale V; Osman SM; AlOthman Z; Supuran CT; Capasso C
Bioorg Med Chem Lett; 2016 Apr; 26(8):1941-6. PubMed ID: 26972117
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrases as targets for medicinal chemistry.
Supuran CT; Scozzafava A
Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
[TBL] [Abstract][Full Text] [Related]
17. Protonography, a powerful tool for analyzing the activity and the oligomeric state of the γ-carbonic anhydrase identified in the genome of Porphyromonas gingivalis.
Del Prete S; De Luca V; Iandolo E; Supuran CT; Capasso C
Bioorg Med Chem; 2015 Jul; 23(13):3747-50. PubMed ID: 25910585
[TBL] [Abstract][Full Text] [Related]
18. An Overview of the Carbonic Anhydrases from Two Pathogens of the Oral Cavity: Streptococcus mutans and Porphyromonas gingivalis.
Capasso C; Supuran CT
Curr Top Med Chem; 2016; 16(21):2359-68. PubMed ID: 27072694
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of a recombinant psychrophilic γ-carbonic anhydrase (NcoCA) identified in the genome of the Antarctic cyanobacteria belonging to the genus Nostoc.
De Luca V; Del Prete S; Vullo D; Carginale V; Di Fonzo P; Osman SM; AlOthman Z; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):810-7. PubMed ID: 26226178
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: an editorial.
Supuran CT
Expert Opin Ther Pat; 2013; 23(6):677-9. PubMed ID: 23461558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
